Bioethics Blogs

Reduced the risk of infection by iPS cells when transplanted

Another major advance in cell reprogramming and in obtaining iPS cells was achieved by researchers at Osaka and Kyoto universities, led by Masoto Nakagawa and Shinya Yamanaka, who succeeded in developing a method by which the cells generated have a lower risk of infection when transplanted. To achieve this, they used laminin-511, a synthetic protein (Scientific Reports online 8-I-2014).

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.